See All Slides - tctmd.com

Slides

Presentation TCT 2012

ROADMAP

Presenter: John O'Connell

October 23, 2012

Presentation TCT 2012

Appropriateness Criteria: Implications for Clinical Practice

Presenter: Monica Losquadro

October 23, 2012

Presentation TCT 2012

CorAssist

Presenter: Mitchell Krucoff

October 23, 2012

Presentation TCT 2012

When Do I Prefer PCI for MVD? The Surgeon's Perspective

Presenter: A. Pieter Kappetein

October 23, 2012

Presentation TCT 2012

TCT-67. Impact of Hemodynamic Support with Impella vs. Intraaortic Balloon Counterpulsation on Prognostically Important Ischemic Endpoints: Results from the PROTECT-II Trial

Presenter: George Dangas

October 23, 2012

Presentation TCT 2012

TCT-19. Fractional Flow Reserved Derived from Computed Tomographic Angiography (FFRCT) for Intermediate Severity Coronary Lesions: Results from the DeFACTO Trial...

Presenter: James Min

October 23, 2012

Presentation TCT 2012

Subcutaneous Defibrillators

Presenter: Gust Bardy

October 23, 2012

Presentation TCT 2012

TCT-43. Final Five-year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients with Three-vessel Disease

Presenter: A. Pieter Kappetein

October 23, 2012

Presentation TCT 2012

WaveCrest (Coherex Medical): Device Iteration, Human Outcomes, and Clinical Trial Directions

Presenter: Saibal Kar

October 23, 2012

Presentation TCT 2012

TCT-82. Cost-effectiveness Of Transcatheter Left Atrial Appendage Occlusion Compared with 5 Alternative Anticoagulation Strategies for Stroke Prevention in Atrial...

Presenter: Bryan Yan

October 23, 2012

Advertisement

Slides

ROADMAP

Appropriateness Criteria: Implications for Clinical Practice

CorAssist

When Do I Prefer PCI for MVD? The Surgeon's Perspective

TCT-67. Impact of Hemodynamic Support with Impella vs. Intraaortic Balloon Counterpulsation on Prognostically Important Ischemic Endpoints: Results from the PROTECT-II Trial

TCT-19. Fractional Flow Reserved Derived from Computed Tomographic Angiography (FFRCT) for Intermediate Severity Coronary Lesions: Results from the DeFACTO Trial...

Subcutaneous Defibrillators

TCT-43. Final Five-year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients with Three-vessel Disease

WaveCrest (Coherex Medical): Device Iteration, Human Outcomes, and Clinical Trial Directions

TCT-82. Cost-effectiveness Of Transcatheter Left Atrial Appendage Occlusion Compared with 5 Alternative Anticoagulation Strategies for Stroke Prevention in Atrial...

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content